S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AKTX Akari Therapeutics PLC

0.97

-0.085 (-8.06%)

Feb 21 2025 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics PLC News

Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Wednesday 19 February 2025 (5 days ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 14 February 2025 (1 week ago) • Edgar (US Regulatory)

Akari Therapeutics Joins Webull Corporate Connect Service Platform
Monday 3 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 10 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

More Akari Therapeutics PLC News Articles

Accredited Solutions (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

North Bay Resources (PK)

Elite Pharmaceuticals (QB)

Bioelectronics (PK)

Intergrated Cannabis Sol... (PK)

Rennova Health (CE)

Fannie Mae (QB)

Digital Brand Media and ... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions